Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium carbonate + calcium galactogluconate is a combination mineral supplement used for the prevention and treatment of calcium deficiency (hypocalcemia). Calcium carbonate provides a high concentration of elemental calcium, while calcium galactogluconate is a highly soluble salt that enhances the overall bioavailability and absorption profile of the formulation. This combination is frequently administered in effervescent tablet form. In clinical practice, such as the protocols studied at the **Hellenic Red Cross Hospital**, it is used prophylactically to mitigate transient hypocalcemia following total thyroidectomy, a common complication resulting from potential parathyroid gland trauma. It is often used in conjunction with vitamin D analogues like alfacalcidol to maintain calcium homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + calcium galactogluconate.